{"name":"Ribocure Pharmaceuticals AB","slug":"ribocure-pharmaceuticals-ab","ticker":"","exchange":"","domain":"ribocureab.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxQbGxpU2VYMU1UckJtRFZNbWZfUHM4ODFYOFZzSmhlQm5qS1hEQnp4TlVSWVRQdjVhajNZZjBwUWttZ1ZISU9vSmxLaEpQV2U1VHI4Y1Y5RnU1MThpNWY4aldlQzhHRjBDSTg1SHJaaTBTR1NaNFlUdlliOE01VkpTcExEY1pid1djbUZDc3VQM1E3WE9LUDJjMg?oc=5","date":"2026-02-12","type":"deal","source":"The Pharma Letter","summary":"Madrigal expands its MASH pipeline via Ribo deal - The Pharma Letter","headline":"Madrigal expands its MASH pipeline via Ribo deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMikAJBVV95cUxOUkwzWE45aWVXRDBsemE3WFQwZ2huVEVZWkRnclZ3S2NkcmNMcWdYQW9KZWRWNzYyX2xwRVVjb0F4V1JxZHJuSVJrNFV0WDFJMlVpUGJQMzRFLWhUVW5raUJfNjFuczJlM1lRaVlXYnp4Zndxbkd1M253LS1EMnEyYUxndlVCUFM1ZGota2dKd0U4UjJHV3ZmN3IwaGpKZHB0am1QWjhTbjVCWXRHNFpnb1dBd2FZYjA1bFpOVFNLbG9zXzdwcXk1dHBtTWI1Z2hvNHlySzFuQ1gtMjhIZlZZbE1kME1vS01NRDF2SFp4c3hXcEJWeFBoWUNFQXZHTGtkakd2TDJZSUZTRmdUOVFrcQ?oc=5","date":"2026-02-11","type":"pipeline","source":"GlobeNewswire","summary":"Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs - GlobeNewswire","headline":"Madrigal Expands its MASH Pipeline with Exclusive Global Licensing Agreement for Six Preclinical siRNA Programs","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiiAJBVV95cUxQd2FISzFkSVRnaUk4SVpxVnNZaWpCU3FVdVVIOUt6YnFDTmloSG5mTWxhTVVRV3FBRlEtM1J0aGhJUDVaZW5pblZ4cjZYSHZpX3NnSWFHVGJCU2JjbUVPUk9nZUJudHFSTnkzMGJyT2Q2QUFKQVpCN1l6SnZjSWhFeERyQ3Y4OTJadExYeUtlLTBPU21WZVU1QzVRLVFyU0dzeUxpVnZKZ2YxOHVZeW04ZFlsYndTLTFDMWFkMmF0RG9QVVZMZzRsaGhWbk1zNFVaZVc0b24zUlowcGNBdVhWb19IejI0a2pXU1YyQ1AzdG1QUmNlVGxhRFBrSGNaay1CQ0w4RGNraUs?oc=5","date":"2026-02-11","type":"pipeline","source":"PR Newswire","summary":"Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MASH - PR Newswire","headline":"Ribo and Ribocure Announce Exclusive Global Licensing Agreement with Madrigal for Novel siRNA Therapeutics Targeting MAS","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxNTTFKcFVYZGc5UXhCMTZ6X0Rmc0ZldkxoeDlETzRlT0JQS0ltN0RZdE52Y0UtWFVKdzc4d3pEdG1fWGVtdXVlcmJ3MlNlTktWcWw0cHRycFlqS0tkdzlVb2hOTVZWcHJLS0NOLWhBcDJmU3VsNGpPaXNsNDJtMUJuZG9BZUMyZUpxdlE5YVFxUEo3TVZ4d2lpV0x2MGpVWHlnOG9wdENLa2lCNjMwd3ZiZzBzMEdHRDFPVjRZY3NHdG4?oc=5","date":"2026-02-11","type":"pipeline","source":"Stock Titan","summary":"Madrigal signs RNA liver drug pact with Ribo worth up to $4.4B - Stock Titan","headline":"Madrigal signs RNA liver drug pact with Ribo worth up to $4.4B","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAJBVV95cUxQMEppWU05MHk5NGZtdXFpbkYxaHk5QS1nQm96ZVZackZOOFM2ZDlzUWd1REp4RjJnZ19uVG00ZnB2MFJlUGFMMUtFeVFsdVR3YmU1QUF1Y1d0VUdHTkF2S3NsbVdyRUxCamJmVUFodEpxNXQwOTBJSGJQT2UxX1ZkUWJ5Q2xoUDdWZHJub1JJajFmWmo4MFFNQ3JYZFNldzQ3S2t3N3ZQc3FPS3NmS3FabUwzYllQUm5rTm5STjlubFMzdE1NeTRvdGFPRFZnWlB0ZnlpeTBTZEVFeGFia3p0Q1VlZUR1aktKU1YyVG1UTEJYQTZmdzd6aFFqSElfRldwcEs0UDViTjJQUkhOWnNJYjdSVEltcTJhSUxfSzJtTW5jWnZW?oc=5","date":"2025-07-02","type":"pipeline","source":"Mynewsdesk","summary":"Distinguished Swedish Investors Back Leading Biotech Company in GoCo Health Innovation City to Advance siRNA Therapies - Mynewsdesk","headline":"Distinguished Swedish Investors Back Leading Biotech Company in GoCo Health Innovation City to Advance siRNA Therapies","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiR0FVX3lxTE9Yb2gxV0pFcWt4Mno2NklKYmxMSzBCTldzUlNkcFp4NWFFR3g3RnpWS2MtOUhYdFUxMXhkckdyRjhiRXVuQ1Mw?oc=5","date":"2024-01-12","type":"pipeline","source":"Oncodaily","summary":"Latest pharma industry updates by Nicolas Schmitz - Oncodaily","headline":"Latest pharma industry updates by Nicolas Schmitz","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxOMTBycmFDa3VYTWMxaWRmNE5qZTV4YWQzcnh2NHRmVW5kRm44WjhnRk84WnR6QXNIOWk3SG40UTNKbmtyRU1lMTlxTlVILWxOdUQ4UlZDcUlpb01OVVZROXdPaGQ3TmlCUEhrRlFCVk9yaUJWYzlFa3FqaVhnNlVuMndUdUgyWHlxR09zaC1KdjlockNPUmRVczQ5dkNsQ3dTZDFKSg?oc=5","date":"2024-01-09","type":"deal","source":"BioWorld News","summary":"Argo, Novartis sign two deals for CV assets for potentially $4B+ - BioWorld News","headline":"Argo, Novartis sign two deals for CV assets for potentially $4B+","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMivgFBVV95cUxPbjFmYmVHN09EWFdPZHlYUjdsLXQxaV9qSGNJQTZHblpwNy1ldG4xN2hsSml4QzR0NkNRU0lGZVlmdWZ2T2RrbnNPakFJamV0MjVneVJMWTlNdGdqVlljcmlGbnRDOXRJWGpwZ05EVTFsZlQwWlBndlpQTXo0WWptU2F2WE03QjhxdTk3YUtyTUZod3JYYWJ4SVZWQTlwOTFDclVVa1VodExyOWc3NVFRT0s5bE5aYkZyTkc3aHFR?oc=5","date":"2024-01-03","type":"deal","source":"European Pharmaceutical Review","summary":"Boehringer Ingelheim agrees $2bn siRNA therapeutic collaboration - European Pharmaceutical Review","headline":"Boehringer Ingelheim agrees $2bn siRNA therapeutic collaboration","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}